Cargando…

Expression of glucose transporters in critical illness

Detalles Bibliográficos
Autores principales:	Langouche, L, Vander Perre, S, Wouters, P, Van den Berghe, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092627/ http://dx.doi.org/10.1186/cc4599

Ejemplares similares

Insulin signaling in critical illness: intensive versus conventional insulin therapy
por: Langouche, L, et al.
Publicado: (2005)

Cortisol metabolism in critical illness: effects of intensive insulin therapy
por: Vanhorebeek, I, et al.
Publicado: (2005)

Alterations in adipose tissue during critical illness: an adaptive and protective response?
por: Langouche, L, et al.
Publicado: (2010)

Critical illness induces nutrient-independent adipogenesis and accumulation of alternatively activated tissue macrophages
por: Marques, M, et al.
Publicado: (2013)

Protection of mitochondria by intensive insulin therapy in critical illness: blood glucose control or insulin?
por: Vanhorebeek, I, et al.
Publicado: (2006)

Effect of intensive insulin therapy on coagulation and fibrinolysis of respiratory critically ill patients
por: Langouche, L, et al.
Publicado: (2007)

Impact of early parenteral nutrition on muscle and adipose tissue compartments during critical illness
por: Langouche, L, et al.
Publicado: (2013)

Strict blood glucose control with insulin improves hepatic mitochondrial ultrastructure and function in critical illness
por: Vanhorebeek, I, et al.
Publicado: (2004)

Organ dysfunction in critical illness: impact of maintaining normoglycemia and glycemia-independent insulin actions
por: Ellger, B, et al.
Publicado: (2006)

Impact of tight glucose control on circulating 3-hydroxybutyrate in critically ill patients
por: Gunst, Jan, et al.
Publicado: (2021)

Reduced cortisol metabolism drives hypercortisolism in critical illness
por: Boonen, E, et al.
Publicado: (2012)

Proliferation and differentiation of adipose tissue in prolonged lean and obese critically ill patients
por: Goossens, Chloë, et al.
Publicado: (2017)

Withholding parenteral nutrition during the first week of critical illness increases plasma bilirubin but lowers the incidence of cholestasis and gallbladder sludge
por: Vanwijngaerden, YM, et al.
Publicado: (2013)

Receptor for advanced glycation end products axis in critically ill patients
por: Ingels, C, et al.
Publicado: (2014)

OR19-06 Sepsis-Induced Critical Illness in Mice Alters Key Regulators of ACTH Production and Secretion Within the Anterior Pituitary Gland
por: Téblick, Arno, et al.
Publicado: (2020)

Glycemic control in critically ill infants and children: achieved quality of control in daily clinical practice in Leuven after a RCT
por: Voets, E, et al.
Publicado: (2011)

Effect of increasing intravenous glucose load in the presence of normoglycemia on outcome and metabolism in critically ill rabbits
por: Derde, S, et al.
Publicado: (2009)

ACTH and cortisol responses to CRH in acute, subacute, and prolonged critical illness: a randomized, double-blind, placebo-controlled, crossover cohort study
por: Peeters, Bram, et al.
Publicado: (2018)

Impact of withholding early parenteral nutrition in adult critically ill patients on ketogenesis in relation to outcome
por: De Bruyn, Astrid, et al.
Publicado: (2021)

Intensive insulin therapy and brief hypoglycemia do not increase neurological injury markers in critically ill children
por: Gielen, M, et al.
Publicado: (2010)

Intensive insulin therapy in critically ill children: impact on blood glucose dynamics and its relation with mortality
por: Van Tornout, M, et al.
Publicado: (2013)

Implementing intensive insulin therapy in daily practice reduces the incidence of critical illness polyneuropathy and/or myopathy
por: Berends, N, et al.
Publicado: (2008)

Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin
por: Langouche, Lies, et al.
Publicado: (2009)

Adrenocortical function during prolonged critical illness and beyond: a prospective observational study
por: Peeters, Bram, et al.
Publicado: (2018)

Fibroblast growth factor 21 response to critical illness: effect of blood glucose control and relation with mitochondrial dysfunction, the integrated stress response and survival
por: Thiessen, S, et al.
Publicado: (2015)

Regulation of type 1 deiodinase activity in prolonged critical illness
por: Debaveye, Y, et al.
Publicado: (2006)

Aberrant bone metabolism in critical illness
por: Vanhees, I, et al.
Publicado: (2012)

Blood glucose amplitude variation: effects of intensive insulin therapy and relative association with mortality
por: Bekaert, E, et al.
Publicado: (2010)

OR26-4 Glucocorticoid Receptor Expression and Signaling During Critical Illness, in Relation to the Duration of Illness and the Systemic Glucocorticoid Availability: A Prospective, Observational, Cross-Sectional Human and a Translational Mouse Study
por: Téblick, Arno, et al.
Publicado: (2022)

SUN-548 Ketone Bodies in Critical Illness Alter Cholesterol Synthesis in Skeletal Muscle, Interlinked with Protection Against Weakness
por: Goossens, Chloë, et al.
Publicado: (2020)

Efficacy and safety of ketone ester infusion to prevent muscle weakness in a mouse model of sepsis-induced critical illness
por: Weckx, Ruben, et al.
Publicado: (2022)

On the Role of Illness Duration and Nutrient Restriction in Cholestatic Alterations that Occur During Critical Illness
por: Jenniskens, Marc, et al.
Publicado: (2018)

Effect of restoration of 25OHD(3 )status in prolonged critical illness on serum innate immunity parameters LL-37 and sCD163
por: Ingels, CM, et al.
Publicado: (2010)

Impact of early versus late parenteral nutrition on morphological and molecular markers of atrophy and autophagy in skeletal muscle of critically ill patients
por: Vanhorebeek, I, et al.
Publicado: (2013)

Critical illness induces alternative activation of M2 macrophages in adipose tissue
por: Langouche, Lies, et al.
Publicado: (2011)

Insufficient activation of autophagy allows accumulation of cellular damage and may contribute to sustained organ failure in prolonged critically ill patients
por: Gunst, J, et al.
Publicado: (2011)

Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate
por: Goossens, Chloë, et al.
Publicado: (2021)

Critical illness induces nutrient-independent adipogenesis and accumulation of alternatively activated tissue macrophages
por: Marques, Mirna Bastos, et al.
Publicado: (2013)

Mechanisms of kidney protection by intensive insulin therapy during critical illness
por: Vanhorebeek, I, et al.
Publicado: (2008)

Anterior pituitary function in critical illness
por: Téblick, Arno, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dktc704h25p1lv62cia9sgsnj7